Partner Laura Labeots Named Among Crain’s 2022 Notable Women in Law
CHICAGO (Sept. 8, 2022) — Lathrop GPM Partner, Laura Labeots, Ph.D., was recently named a 2022 Notable Women in Law honoree by Crain’s Chicago Business. The recognition highlights “women who have a track record of setting legal precedents, winning big cases for their clients and mentoring the next wave of women in law — all while finding ways to give back to their communities.” This is the second time Dr. Labeots has received this honor.
An intellectual property partner in the firm’s Chicago office, Dr. Labeots advises on worldwide patent drafting and prosecution, litigation, opinion work (freedom-to-operate, patentability, invalidity, and infringement analyses), due diligence, licensing, trade secrets, trademark prosecution and litigation, and inter partes review proceedings before the U.S. Patent and Trademark Office.
Dr. Labeots recent, noteworthy experience includes:
- Working with a Nobel Prize winner on designing and implementing a patent prosecution strategy for genetic engineering technology.
- Assisting an Ivy League higher education institution build a patent portfolio in domestic and international arenas for CRISPR-related technologies.
- Advising a nonprofit company working on cures for Alzheimer’s disease in patent matters.
- Guiding a start-up company obtain worldwide patent protection for pharmaceutical agents comprising natural products.
- Defending a major producer of biofuel in litigation at the Federal Circuit.
- Working on an Appeal at the PTAB for pharmaceutical formulation patents for a major biotech company.
- Representing a privately held company pioneering laser technology in expanding worldwide patent matters.
- Designing and executing a worldwide patent prosecution strategy for one of the largest flooring manufacturers in the US.
In addition, Dr. Labeots is an active member of the Lathrop GPM Women’s Initiative Network that provides support, firmwide networking, and mentoring for women attorneys and is a former co-chair of the Intellectual Property Law Association of Chicago’s Biotech Committee as well as a member of Licensing Executives Society, MATTER, PROPEL, and Women in Bio.